STEPHENS INC /AR/ - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 45 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$37,000
+68.2%
28,000
+55.6%
0.00%
Q4 2021$22,000
-8.3%
18,0000.0%0.00%
Q3 2021$24,0000.0%18,0000.0%0.00%
Q2 2021$24,0000.0%18,0000.0%0.00%
Q1 2021$24,000
+9.1%
18,000
+12.5%
0.00%
Q4 2020$22,0000.0%16,0000.0%0.00%
Q3 2020$22,000
-18.5%
16,0000.0%0.00%
-100.0%
Q2 2020$27,000
+28.6%
16,0000.0%0.00%0.0%
Q1 2020$21,00016,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders